Identi Healthcare Ltd (TLV:IDNT)
Israel · Delayed Price · Currency is ILS · Price in ILA 158.00
+0.10 (0.06%)
Sep 10, 2026, 5:24 PM IDT
Identi Healthcare Income Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12.44 | 9.9 | 10.09 | 10.05 | 9.46 | 8.08 | |
Revenue Growth | 13.76% | -1.89% | 0.39% | 6.28% | 17.10% | 13.78% |
Cost of Revenue | 6.44 | 5.24 | 6.01 | 6.38 | 5.05 | 4.75 |
Gross Profit | 6 | 4.66 | 4.08 | 3.67 | 4.4 | 3.32 |
Selling, General & Admin | 7.04 | 7.05 | 6.94 | 7.25 | 7.45 | 3.14 |
Research & Development | 3.32 | 3.23 | 3.44 | 3.43 | 3.71 | 6.18 |
Other Operating Expenses | -0.1 | -0.1 | - | - | - | - |
Operating Expenses | 10.26 | 10.18 | 10.39 | 10.68 | 11.15 | 9.31 |
Operating Income | -4.26 | -5.52 | -6.31 | -7.01 | -6.75 | -5.99 |
Interest Expense | -0.3 | -0.15 | -0.11 | -0.12 | -0.09 | -0.08 |
Interest & Investment Income | 0.15 | 0.21 | 0.17 | 0.37 | 0.04 | - |
Currency Exchange Gain (Loss) | -0.27 | -0.27 | - | 0 | 0.17 | -0.04 |
Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.01 | -0.02 | 0.04 | 0.1 |
Pretax Income | -4.71 | -5.77 | -6.25 | -6.78 | -6.6 | -6.01 |
Income Tax Expense | 0.02 | 0.01 | 0.01 | - | 0.56 | -0.34 |
Net Income | -4.74 | -5.78 | -6.26 | -6.78 | -7.15 | -5.67 |
Net Income to Common | -4.74 | -5.78 | -6.26 | -6.78 | -7.15 | -5.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 15 | 14 | 13 | 13 | 13 | 11 |
Shares Outstanding (Diluted) | 15 | 14 | 13 | 13 | 13 | 11 |
Shares Change | 16.42% | 14.72% | 0.06% | - | 15.17% | 21.59% |
EPS (Basic) | -0.31 | -0.40 | -0.50 | -0.54 | -0.57 | -0.52 |
EPS (Diluted) | -0.32 | -0.40 | -0.50 | -0.54 | -0.57 | -0.52 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.01 | -5.92 | -4.08 | -6.17 | -6.9 | -3.11 |
Free Cash Flow Per Share | -0.33 | -0.41 | -0.32 | -0.49 | -0.55 | -0.28 |
Gross Margin | 48.24% | 47.07% | 40.43% | 36.53% | 46.56% | 41.15% |
Operating Margin | -34.24% | -55.75% | -62.52% | -69.73% | -71.38% | -74.17% |
Profit Margin | -38.07% | -58.34% | -62.02% | -67.43% | -75.63% | -70.23% |
Free Cash Flow Margin | -40.31% | -59.85% | -40.44% | -61.38% | -72.98% | -38.56% |
EBITDA | -3.66 | -5.42 | -6.2 | -6.59 | -6.39 | -5.74 |
EBITDA Margin | -29.45% | -54.73% | -61.46% | -65.53% | -67.53% | -71.06% |
D&A For EBITDA | 0.6 | 0.1 | 0.11 | 0.42 | 0.36 | 0.25 |
EBIT | -4.26 | -5.52 | -6.31 | -7.01 | -6.75 | -5.99 |
EBIT Margin | -34.24% | -55.75% | -62.52% | -69.73% | -71.38% | -74.17% |
Advertising Expenses | - | 0.84 | 0.75 | 1.11 | 1.72 | 0.68 |